mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0005 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |